Bulletin of Chinese Academy of Sciences (Chinese Version)


life sciences, scientific research institution, Broad Institute, cutting-edge innovation

Document Type

Policy & Management Research


Since its establishment in 2004, the Broad Institute in the United States has been dedicated to combination research innovation with management innovation. In less than 10 years, it has been enlisted as one of the world-class life sciences research institutions and become the leader and signpost of cutting-edge innovation in life sciences. Its unique development model is worthy of reference. This study showed that the high-quality innovation and development of the Broad Institute is inseparable from:(1) its focus on the diagnosis and treatment needs of major diseases for scientific research; (2) the opening up of the channel from basic research to transformation and application; (3) the formation of an interdisciplinary and multi-level integrated research model; (4) its giving full play to the leading role of strategic scientists; (5) the gathering effect of small and excellent teams of outstanding scientists; (6) the implementation of highly flexible project organization and management; (7) the building of a first-class innovation network radiating the world. China can learn from its experience to promote the cutting-edge innovation of life sciences from following four aspects:(1) taking life sciences as the breakthrough in building China as a scientific and technological strength; (2) strengthening upper-level design for people's life and health; (3) laying a solid foundation of human resources of life sciences; (4) deeply integrating into the global innovation network of life sciences.

First page


Last Page





Bulletin of Chinese Academy of Sciences


1 Broad Institute. Broad Institute 2012. Boston:Broad Institute, 2013. 2 Regev A, Teichmann S A, Lander E S, et al. The human cell atlas. eLife, 2017, 6:e27041. 3 Boehm J S, Garnett M J, Adams D J, et al. Cancer research needs a better map. Nature, 2021, 589:514-516. 4 汤森路透. 开放的未来:2015全球创新报告. 科学观察, 2015, 10(4):18-70. Thomson Reuters. The future is open-2015 state of innovation. Science Focus, 2015, 10(4):18-70. 5 Gaudelli N M, Komor A C, Rees H A, et al. Programmable base editing of A·T to G·C in genomic DNA without DNA cleavage. Nature, 2017, 551:464-471. 6 Weinstein J A, Regev A, Zhang F. DNA microscopy:Opticsfree spatio-genetic imaging by a stand-alone chemical reaction. Cell, 2019, 178(1):229-241. 7 Jin X, Demere Z, Nair K, et al. A metastasis map of human cancer cell lines. Nature, 2020, 588:331-336. 8 Segel M, Lash B, Song J W, et al. Mammalian retroviruslike protein PEG10 packages its own mRNA and can be pseudotyped for mRNA delivery. Science, 2021, 373:882-889. 9 Clarivate Analytics. Highly Cited Researchers 2020. (2020-11-18)[2021-07-07]. https://recognition.webofscience.com/awards/highly-cited/2020/. 10 Barretina J, Caponigro G, Stransky N, et al. The Cancer Cell Line Encyclopedia enables predictive modelling of anticancer drug sensitivity. Nature, 2012, 483:603-607. 11 Yu C, Mannan A M, Yvone G M, et al. High-throughput identification of genotype-specific cancer vulnerabilities in mixtures of barcoded tumor cell lines. Nature Biotechnology, 2016, 34(4):419-423. 12 Corsello S M, Nagari R T, Spangler R D, et al. Discovering the anticancer potential of non-oncology drugs by systematic viability profiling. Nature Cancer, 2020, 1(2):235-248. 13 Cong L, Ran F A, Cox D, et al. Multiplex genome engineering using CRISPR/Cas systems. Science, 2013, 339:819-823. 14 Ran F A, Cong L, Yan W X, et al. In vivo genome editing using Staphylococcus aureus Cas9. Nature, 2015, 520:186-191. 15 Zetsche B, Gootenberg J S, Abudayyeh O O, et al. Cpf1 is a single RNA-guided endonuclease of a class 2 CRISPR-Cas system. Cell, 2015, 163(3):759-771. 16 Cox D B T, Gootenberg J S, Abudayyeh O O, et al. RNA editing with CRISPR-Cas13. Science, 2017, 358:1019-1027. 17 Anzalone A V, Randolph P B, Davis J R, et al. Search-andreplace genome editing without double-strand breaks or donor DNA. Nature, 2019, 576:149-157. 18 Patchsung M, Jantarug K, Pattama A, et al. Clinical validation of a Cas13-based assay for the detection of SARS-CoV-2 RNA. Nature Biomedical Engineering, 2020, 4(12):1140-1149. 19 Yeh W H, Shubina-Oleinik O, Levy J M, et al. In vivo base editing restores sensory transduction and transiently improves auditory function in a mouse model of recessive deafness. Science Translational Medicine, 2020, 12:eaay9101.